In Vitro Diagnostic/IVD Market Report

Global In Vitro Diagnostic/IVD Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 03, 2022
  • PAGES：200
  • REPORT CODE：GMM796275
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • In Vitro Diagnostic/IVD market report explains the definition, types, applications, major countries, and major players of the In Vitro Diagnostic/IVD market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • QIAGEN (Germany)

    • Ortho Clinical Diagnostics (US)

    • DiaSorin (Italy)

    • Thermo Fisher Scientific (US)

    • Roche Diagnostics (Switzerland)

    • Johnson & Johnson (US)

    • Bio-Rad Laboratories (US)

    • Siemens Healthineers (Germany)

    • Danaher Corporation (US)

    • Abbott Laboratories (US)

    • Agilent Technologies (US)

    • bioMérieux (France)

    • Sysmex Corporation (Japan)

    By Type:

    • Instruments

    • Reagents

    By End-User:

    • Diabetes

    • Oncology

    • Cardiology

    • Nephrology

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global In Vitro Diagnostic/IVD Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 In Vitro Diagnostic/IVD Outlook to 2028- Original Forecasts

    • 2.2 In Vitro Diagnostic/IVD Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term In Vitro Diagnostic/IVD Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global In Vitro Diagnostic/IVD Market- Recent Developments

    • 6.1 In Vitro Diagnostic/IVD Market News and Developments

    • 6.2 In Vitro Diagnostic/IVD Market Deals Landscape

    7 In Vitro Diagnostic/IVD Raw Materials and Cost Structure Analysis

    • 7.1 In Vitro Diagnostic/IVD Key Raw Materials

    • 7.2 In Vitro Diagnostic/IVD Price Trend of Key Raw Materials

    • 7.3 In Vitro Diagnostic/IVD Key Suppliers of Raw Materials

    • 7.4 In Vitro Diagnostic/IVD Market Concentration Rate of Raw Materials

    • 7.5 In Vitro Diagnostic/IVD Cost Structure Analysis

      • 7.5.1 In Vitro Diagnostic/IVD Raw Materials Analysis

      • 7.5.2 In Vitro Diagnostic/IVD Labor Cost Analysis

      • 7.5.3 In Vitro Diagnostic/IVD Manufacturing Expenses Analysis

    8 Global In Vitro Diagnostic/IVD Import and Export Analysis (Top 10 Countries)

    • 8.1 Global In Vitro Diagnostic/IVD Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global In Vitro Diagnostic/IVD Export by Region (Top 10 Countries) (2017-2028)

    9 Global In Vitro Diagnostic/IVD Market Outlook by Types and Applications to 2022

    • 9.1 Global In Vitro Diagnostic/IVD Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Instruments Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Reagents Consumption and Growth Rate (2017-2022)

    • 9.2 Global In Vitro Diagnostic/IVD Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Nephrology Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise In Vitro Diagnostic/IVD Market Analysis and Outlook till 2022

    • 10.1 Global In Vitro Diagnostic/IVD Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.2.2 Canada In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.2.3 Mexico In Vitro Diagnostic/IVD Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.2 UK In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.3 Spain In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.4 Belgium In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.5 France In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.6 Italy In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.7 Denmark In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.8 Finland In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.9 Norway In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.10 Sweden In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.11 Poland In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.12 Russia In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.3.13 Turkey In Vitro Diagnostic/IVD Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.2 Japan In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.3 India In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.4 South Korea In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.5 Pakistan In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.6 Bangladesh In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.7 Indonesia In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.8 Thailand In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.9 Singapore In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.10 Malaysia In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.11 Philippines In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.4.12 Vietnam In Vitro Diagnostic/IVD Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.5.2 Colombia In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.5.3 Chile In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.5.4 Argentina In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.5.5 Venezuela In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.5.6 Peru In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.5.7 Puerto Rico In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.5.8 Ecuador In Vitro Diagnostic/IVD Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.6.2 Kuwait In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.6.3 Oman In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.6.4 Qatar In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.6.5 Saudi Arabia In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.6.6 United Arab Emirates In Vitro Diagnostic/IVD Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.7.2 South Africa In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.7.3 Egypt In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.7.4 Algeria In Vitro Diagnostic/IVD Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia In Vitro Diagnostic/IVD Consumption (2017-2022)

      • 10.8.2 New Zealand In Vitro Diagnostic/IVD Consumption (2017-2022)

    11 Global In Vitro Diagnostic/IVD Competitive Analysis

    • 11.1 QIAGEN (Germany)

      • 11.1.1 QIAGEN (Germany) Company Details

      • 11.1.2 QIAGEN (Germany) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 QIAGEN (Germany) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.1.4 QIAGEN (Germany) In Vitro Diagnostic/IVD Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Ortho Clinical Diagnostics (US)

      • 11.2.1 Ortho Clinical Diagnostics (US) Company Details

      • 11.2.2 Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.2.4 Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 DiaSorin (Italy)

      • 11.3.1 DiaSorin (Italy) Company Details

      • 11.3.2 DiaSorin (Italy) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 DiaSorin (Italy) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.3.4 DiaSorin (Italy) In Vitro Diagnostic/IVD Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Thermo Fisher Scientific (US)

      • 11.4.1 Thermo Fisher Scientific (US) Company Details

      • 11.4.2 Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.4.4 Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Roche Diagnostics (Switzerland)

      • 11.5.1 Roche Diagnostics (Switzerland) Company Details

      • 11.5.2 Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.5.4 Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Johnson & Johnson (US)

      • 11.6.1 Johnson & Johnson (US) Company Details

      • 11.6.2 Johnson & Johnson (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Johnson & Johnson (US) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.6.4 Johnson & Johnson (US) In Vitro Diagnostic/IVD Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Bio-Rad Laboratories (US)

      • 11.7.1 Bio-Rad Laboratories (US) Company Details

      • 11.7.2 Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.7.4 Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Siemens Healthineers (Germany)

      • 11.8.1 Siemens Healthineers (Germany) Company Details

      • 11.8.2 Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.8.4 Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Danaher Corporation (US)

      • 11.9.1 Danaher Corporation (US) Company Details

      • 11.9.2 Danaher Corporation (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Danaher Corporation (US) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.9.4 Danaher Corporation (US) In Vitro Diagnostic/IVD Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Abbott Laboratories (US)

      • 11.10.1 Abbott Laboratories (US) Company Details

      • 11.10.2 Abbott Laboratories (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Abbott Laboratories (US) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.10.4 Abbott Laboratories (US) In Vitro Diagnostic/IVD Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Agilent Technologies (US)

      • 11.11.1 Agilent Technologies (US) Company Details

      • 11.11.2 Agilent Technologies (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Agilent Technologies (US) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.11.4 Agilent Technologies (US) In Vitro Diagnostic/IVD Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 bioMérieux (France)

      • 11.12.1 bioMérieux (France) Company Details

      • 11.12.2 bioMérieux (France) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 bioMérieux (France) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.12.4 bioMérieux (France) In Vitro Diagnostic/IVD Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Sysmex Corporation (Japan)

      • 11.13.1 Sysmex Corporation (Japan) Company Details

      • 11.13.2 Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Main Business and Markets Served

      • 11.13.4 Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global In Vitro Diagnostic/IVD Market Outlook by Types and Applications to 2028

    • 12.1 Global In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Instruments Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Reagents Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Nephrology Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise In Vitro Diagnostic/IVD Market Analysis and Outlook to 2028

    • 13.1 Global In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.2.2 Canada In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.2.3 Mexico In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.2 UK In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.3 Spain In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.4 Belgium In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.5 France In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.6 Italy In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.7 Denmark In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.8 Finland In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.9 Norway In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.10 Sweden In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.11 Poland In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.12 Russia In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.3.13 Turkey In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.2 Japan In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.3 India In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.4 South Korea In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.8 Thailand In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.9 Singapore In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.11 Philippines In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.5.2 Colombia In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.5.3 Chile In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.5.4 Argentina In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.5.6 Peru In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.6.3 Oman In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.6.4 Qatar In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.7.2 South Africa In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.7.3 Egypt In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.7.4 Algeria In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand In Vitro Diagnostic/IVD Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of In Vitro Diagnostic/IVD

    • Figure of In Vitro Diagnostic/IVD Picture

    • Table Global In Vitro Diagnostic/IVD Import by Region (Top 10 Countries) (2017-2028)

    • Table Global In Vitro Diagnostic/IVD Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Instruments Consumption and Growth Rate (2017-2022)

    • Figure Global Reagents Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Nephrology Consumption and Growth Rate (2017-2022)

    • Figure Global In Vitro Diagnostic/IVD Consumption by Country (2017-2022)

    • Table North America In Vitro Diagnostic/IVD Consumption by Country (2017-2022)

    • Figure United States In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Canada In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Mexico In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Table Europe In Vitro Diagnostic/IVD Consumption by Country (2017-2022)

    • Figure Germany In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure UK In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Spain In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Belgium In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure France In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Italy In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Denmark In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Finland In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Norway In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Sweden In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Poland In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Russia In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Turkey In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Table APAC In Vitro Diagnostic/IVD Consumption by Country (2017-2022)

    • Figure China In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Japan In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure India In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure South Korea In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Pakistan In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Indonesia In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Thailand In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Singapore In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Malaysia In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Philippines In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Vietnam In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Table South America In Vitro Diagnostic/IVD Consumption by Country (2017-2022)

    • Figure Brazil In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Colombia In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Chile In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Argentina In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Venezuela In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Peru In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Ecuador In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Table GCC In Vitro Diagnostic/IVD Consumption by Country (2017-2022)

    • Figure Bahrain In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Kuwait In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Oman In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Qatar In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Table Africa In Vitro Diagnostic/IVD Consumption by Country (2017-2022)

    • Figure Nigeria In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure South Africa In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Egypt In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure Algeria In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Table Oceania In Vitro Diagnostic/IVD Consumption by Country (2017-2022)

    • Figure Australia In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Figure New Zealand In Vitro Diagnostic/IVD Consumption and Growth Rate (2017-2022)

    • Table QIAGEN (Germany) Company Details

    • Table QIAGEN (Germany) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN (Germany) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table QIAGEN (Germany) In Vitro Diagnostic/IVD Product Portfolio

    • Table Ortho Clinical Diagnostics (US) Company Details

    • Table Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Product Portfolio

    • Table DiaSorin (Italy) Company Details

    • Table DiaSorin (Italy) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table DiaSorin (Italy) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table DiaSorin (Italy) In Vitro Diagnostic/IVD Product Portfolio

    • Table Thermo Fisher Scientific (US) Company Details

    • Table Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Product Portfolio

    • Table Roche Diagnostics (Switzerland) Company Details

    • Table Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Product Portfolio

    • Table Johnson & Johnson (US) Company Details

    • Table Johnson & Johnson (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson (US) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Johnson & Johnson (US) In Vitro Diagnostic/IVD Product Portfolio

    • Table Bio-Rad Laboratories (US) Company Details

    • Table Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Product Portfolio

    • Table Siemens Healthineers (Germany) Company Details

    • Table Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Product Portfolio

    • Table Danaher Corporation (US) Company Details

    • Table Danaher Corporation (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Corporation (US) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Danaher Corporation (US) In Vitro Diagnostic/IVD Product Portfolio

    • Table Abbott Laboratories (US) Company Details

    • Table Abbott Laboratories (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories (US) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Abbott Laboratories (US) In Vitro Diagnostic/IVD Product Portfolio

    • Table Agilent Technologies (US) Company Details

    • Table Agilent Technologies (US) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies (US) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Agilent Technologies (US) In Vitro Diagnostic/IVD Product Portfolio

    • Table bioMérieux (France) Company Details

    • Table bioMérieux (France) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table bioMérieux (France) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table bioMérieux (France) In Vitro Diagnostic/IVD Product Portfolio

    • Table Sysmex Corporation (Japan) Company Details

    • Table Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Main Business and Markets Served

    • Table Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Product Portfolio

    • Figure Global Instruments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Reagents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nephrology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global In Vitro Diagnostic/IVD Consumption Forecast by Country (2022-2028)

    • Table North America In Vitro Diagnostic/IVD Consumption Forecast by Country (2022-2028)

    • Figure United States In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe In Vitro Diagnostic/IVD Consumption Forecast by Country (2022-2028)

    • Figure Germany In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure France In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC In Vitro Diagnostic/IVD Consumption Forecast by Country (2022-2028)

    • Figure China In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure India In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Table South America In Vitro Diagnostic/IVD Consumption Forecast by Country (2022-2028)

    • Figure Brazil In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC In Vitro Diagnostic/IVD Consumption Forecast by Country (2022-2028)

    • Figure Bahrain In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa In Vitro Diagnostic/IVD Consumption Forecast by Country (2022-2028)

    • Figure Nigeria In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania In Vitro Diagnostic/IVD Consumption Forecast by Country (2022-2028)

    • Figure Australia In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand In Vitro Diagnostic/IVD Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US